Trial Profile
A comparative study of Humalog Mix25 versus Humalog Mix50
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2018 Results of a post-hoc analysis assessing the contribution rates of BHG and PPHG to overall hyperglycemia in the T2DM patients treated with LM25 and LM50, published in the Diabetes Therapy
- 01 Apr 2018 Results published in the Diabetes Therapy
- 12 Mar 2018 Status changed from recruiting to completed.